Nanocell Therapeutics

About Nanocell Therapeutics

NanoCell Therapeutics is a privately-held biotechnology company with offices in King of Prussia, Pennsylvania, and Utrecht, the Netherlands. Our mission is to revolutionize in-vivo cell engineering through our groundbreaking non-viral, DNA-based gene therapy platform, primarily focusing on oncology and autoimmune diseases. At NanoCell, we’re driving innovation by transforming traditional adoptive cell therapy methods into advanced in-vivo treatments. Our ultimate goal is to simplify the treatment process, increasing patient accessibility, potential clinical benefits, and cost-effective manufacturing. We work both autonomously and in collaboration with partners to make substantial advancements in our targeted disease areas. For more information, visit http://www.nanocelltx.com).

Keywords

• Biotechnology
• Gene Therapy
• In-Vivo Gene Therapy

Address

• Headquarters

  BolognalaanUtrechtUtrecht, Netherlands

Team by function

Based on 13 public job profiles as of 4 September 2026.

• Research / R&D6
• Other / Unclassifiable4
• Engineering / Software Development1
• Founder / Owner1
• Operations1